Routine echocardiography screening for left-ventricular dysfunction in childhood cancer survivors: a model-based estimation of the clinical and economic impacts

摘要

BackgroundChildhood cancer survivors treated with cardiotoxic therapies are recommended to undergo routine cardiac assessment every 1 to 5 years, yet the long-term benefits are uncertain.